Optimer falls on 1Q13 financial results

Optimer Pharmaceuticals Inc. (NASDAQ:OPTR) fell $2.11 (14%) to $12.81 on Friday after reporting 1Q13 financial results late Thursday that missed the Street. The company reported a 1Q13 loss per share ...